GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InflaRx NV (STU:IF0) » Definitions » Shiller PE Ratio

InflaRx NV (STU:IF0) Shiller PE Ratio : (As of May. 01, 2025)


View and export this data going back to 2017. Start your Free Trial

What is InflaRx NV Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


InflaRx NV Shiller PE Ratio Historical Data

The historical data trend for InflaRx NV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InflaRx NV Shiller PE Ratio Chart

InflaRx NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

InflaRx NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InflaRx NV's Shiller PE Ratio

For the Biotechnology subindustry, InflaRx NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Shiller PE Ratio falls into.


;
;

InflaRx NV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

InflaRx NV's E10 for the fiscal year that ended in Dec24 is calculated as:

For example, InflaRx NV's adjusted earnings per share data for the fiscal year that ended in Dec24 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec24 (Change)*Current CPI (Dec24)
=-0.78/127.0412*127.0412
=-0.780

Current CPI (Dec24) = 127.0412.

InflaRx NV Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201512 -0.210 99.717 -0.268
201612 -0.382 101.217 -0.479
201712 -2.600 102.617 -3.219
201812 -1.190 104.217 -1.451
201912 -2.050 105.818 -2.461
202012 -1.260 105.518 -1.517
202112 -1.100 110.384 -1.266
202212 -0.670 119.345 -0.713
202312 -0.780 123.773 -0.801
202412 -0.780 127.041 -0.780

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


InflaRx NV  (STU:IF0) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


InflaRx NV Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of InflaRx NV's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


InflaRx NV Business Description

Traded in Other Exchanges
Address
Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

InflaRx NV Headlines

No Headlines